Aarti Industries shareholders approve special resolution to raise up to ₹1,000 crore
Aarti Industries · Chemicals & Petrochemicals
What the filing says
- EGM held on October 31, 2026 through video conferencing (VC/OAVM), with remote e-voting before the meeting
- Special resolution to raise funds up to Rs. 1,000 crore via private offerings, QIPs, or any other permitted method passed
- Votes in favour 258,522,470 (97.6037%), against 6,347,056 (2.3963%), out of 264,869,526 votes polled on 362,741,364 shares
Why it's rated notable: amount is ₹500 crore or more
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Aarti Industries
- Order winMajor developmentAarti Industries Q2 FY27 revenue, EBITDA at record levels; PAT up 60% YoY
- Fundraise / allotmentNotableAarti Industries Ltd approves enabling resolution to raise up to ₹1,000 crore
- Board / shareholder meeting outcomeNotableAarti Industries Limited announces voting results from 43rd AGM held on Sept 21, 2026
- Capex / expansionNotableAarti Industries Commissions Phase I of Zone IV Manufacturing Facility
Other fundraise / allotment filings this fortnight
- Grand Oak Canyons board to consider Rs. 20,67,00,00,000 NCPS allotment on 5 Nov
- Ola Electric approves allotment of 37,02,72,665 partly paid shares in rights issue
- Neogen Chemicals reports Q2 FY27 revenues of ₹296 crore, 42% YoY growth
- Evonile Pharma receives BSE in-principle approval for ₹900 crore rights issue
- Evonile Pharma receives BSE approval for ₹90 crore Rights Issue, board meeting set
- Neogen Chemicals Sept-quarter results, ₹600 crore QIP and ₹200 crore NCD redemption plan
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.